Análise do risco de desenvolvimento de doenças cardiovasculares na população atendida em uma unidade básica de saúde do meio-oeste de Santa Catarina

Kendra Cavassola; Marcos Vinicios Folador; Marcos Otávio Bueno; Leonardo da Silva Santos; Gustavo Colombo Dal-Pont; Ariana Centa

doi:10.5712/rbmfc21(48)4538

Authors

Kendra Cavassola Universidade Alto Vale do Rio do Peixe – Caçador (SC), Brazil
Marcos Vinicios Folador Universidade Alto Vale do Rio do Peixe, Laboratório de Pesquisa Translacional em Saúde – Caçador (SC), Brazil
Marcos Otávio Bueno Universidade Alto Vale do Rio do Peixe, Laboratório de Pesquisa Translacional em Saúde – Caçador (SC), Brazil
Leonardo da Silva Santos Unidade Básica de Saúde Amarante – Videira (SC), Brazil
Gustavo Colombo Dal-Pont Universidade Alto Vale do Rio do Peixe, Laboratório de Pesquisa Translacional em Saúde – Caçador (SC), Brazil https://orcid.org/0000-0003-2164-9653
Ariana Centa Universidade Alto Vale do Rio do Peixe, Laboratório de Pesquisa Translacional em Saúde – Caçador (SC), Brazil

DOI:

https://doi.org/10.5712/rbmfc21(48)4538

Keywords:

Cardiovascular diseases, Hypertension, Risk factors

Abstract

Introduction: Cardiovascular diseases stand as the primary global causes of death, linked to modifiable factors like hypertension, diabetes, smoking, and dyslipidemia. Objective: This study aims to assess the prevalence of high cardiovascular risk among individuals aged 30 to 74 in a Health Basic Unit (Unidade Básica de Saúde – UBS) in Santa Catarina. Methods: Of the total number of medical records, those of 350 patients (235 women, 115 men) were selected for application of the Framingham Score. Results: The results revealed that 40% of men and 15% of women had a high cardiovascular risk. The main risk factors identified were Diabetes mellitus, use of medication for hypertension and age. Hypertension was present in 53.14% of patients, with 40.54% being smokers. Among diabetics, 70.96% of males and 50.8% of females displayed elevated cardiovascular risk. Total cholesterol had an impact on cardiovascular risk, being higher in females. Conclusions: It is concluded that several factors contribute to cardiovascular risk, including age, blood pressure, total cholesterol, HDL, antihypertensive medication, and smoking, all of which result from the interaction of multiple risk factors. Diabetes, antihypertensive medication, and age stand out as the most relevant factors. Increases in HDL indicate risk reduction, particularly among females. Conversely, the elevation of total cholesterol exerted a greater influence on cardiovascular risk in females, while smoking had greater significance in males.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Malta DC, Pinheiro PC, Teixeira RA, Machado IE, Santos FM, Ribeiro ALP. Estimativas do risco cardiovascular em dez anos na população brasileira: um estudo de base populacional. Arq Bras Cardiol. 2021;116(3):423-31. https://doi.org/10.36660/abc.20190861 DOI: https://doi.org/10.36660/abc.20190861

Teixeira MEF, Vitorino PVO, Amodeo C, Martinez T, Brandão AA, Barbosa ECD, et al. Fatores de risco cardiovascular em cardiologistas especialistas pela Sociedade Brasileira de Cardiologia. Arq Bras Cardiol. 2021;116(4):774-81. https://doi.org/10.36660/abc.20200125 DOI: https://doi.org/10.36660/abc.20200125

Alves J. Saúde cardiovascular e seus determinantes sociais: uma revisão. X Jornada Internacional de Políticas Públicas [Internet]. 2021 [acessado em 21 set. 2024]. Disponível em: https://www.joinpp.ufma.br/jornadas/joinpp2021/upload/anais/trabalho_submissaoId_797_7976122b61d66ca5.pdf?070905

Santos JE, Guimarães AC, Diament J. Consenso brasileiro sobre dislipidemias detecção, avaliação e tratamento. Arq Bras Endocrinol Metabol. 1999;43(4)287-305. https://doi.org/10.1590/S0004-27301999000400005 DOI: https://doi.org/10.1590/S0004-27301999000400005

Zão A, Magalhães S, Santos M. Frailty in cardiovascular disease: screening tools. Rev Port Cardiol. 2019;38(2):143-58. https://doi.org/10.1016/j.repc.2018.05.019 DOI: https://doi.org/10.1016/j.repc.2018.05.019

Andersson C, Johnson AD, Benjamin EJ, Levy D, Vasan RS. 70-year legacy of the Framingham Heart Study. Nat Rev Cardiol. 2019;16(11):687-98. https://doi.org/10.1038/s41569-019-0202-5 DOI: https://doi.org/10.1038/s41569-019-0202-5

Mahmood SS, Levy D, Vasan RS, Wang TJ. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet. 2014;383(9921):999-1008. https://doi.org/10.1016/S0140-6736(13)61752-3 DOI: https://doi.org/10.1016/S0140-6736(13)61752-3

Larré M, Almeida EC. Escore de Framingham na avaliação do risco cardiovascular em diabéticos. Rev Rene. 2014;15(6):908-14. https://doi.org/10.15253/2175-6783.2014000600002 DOI: https://doi.org/10.15253/2175-6783.2014000600002

Kim ESH, Arya S, Bryce Y, Gornik HL, Long CA, McDermott MM, et al. Sex differences in peripheral vascular disease: a scientific statement from the American Heart Association. Circulation. 2025;151(14):e877-e904. https://doi.org/10.1161/cir.0000000000001310 DOI: https://doi.org/10.1161/CIR.0000000000001310

Kwak S, Lee HJ, Kim S, Park JB, Lee SP, Kim HK, et al. Machine learning reveals sex-specific associations between cardiovascular risk factors and incident atherosclerotic cardiovascular disease. Sci Rep. 2023;13(1):9364. https://doi.org/10.1038/s41598-023-36450-4 DOI: https://doi.org/10.1038/s41598-023-36450-4

Cichocki M, Fernandes KP, Castro-Alves DC, Gomes MVM. Atividade física e modulação do risco cardiovascular. Rev Bras Med Esporte. 2017;23(1):21-5. https://doi.org/10.1590/1517-869220172301159475 DOI: https://doi.org/10.1590/1517-869220172301159475

Global Cardiovascular Risk Consortium, Alegre-Diaz J, Al-Nasser LA, Amouyel P, Aviles-Santa L, Bakker SJL, et al. The global cardiovascular risk factors on lifetime estimates. N Engl J Med. 2025;393(2):125-38. https://doi.org/10.1056/nejmoa2415879 DOI: https://doi.org/10.1056/NEJMoa2415879

Teixeira MP, Queiroga TP, Mesquita MA. Frequency and risk factors for the birth of small-for-gestational-age newborns in a public maternity hospital. Einstein (São Paulo). 2016;14(3):317-23. https://doi.org/10.1590/s1679-45082016ao3684 DOI: https://doi.org/10.1590/S1679-45082016AO3684

Blood Pressure Lowering Treatment Trialists’ Collaboration. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis. Lancet. 2021;397(10285):1625-36. https://doi.org/10.1016/S0140-6736(21)00590-0 DOI: https://doi.org/10.1016/S0140-6736(21)00590-0

Wong ND, Sattar N. Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention. Nat Rev Cardiol. 2023;20(10):685-95. https://doi.org/10.1038/s41569-023-00877-z DOI: https://doi.org/10.1038/s41569-023-00877-z

Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1998;279(20):1615-22. https://doi.org/10.1001/jama.279.20.1615 DOI: https://doi.org/10.1001/jama.279.20.1615

Silva LSG, Bertolin DC. Risco cardiovascular entre pessoas com DM2: revisão da literatura. Rev Corp Hippocraticum. 2022;2(1).

Silva AS, Alcafache C, Mota M. Alterações estruturais e funcionais do coração em indivíduos fumadores. Higeia. 2021;5(1):21-30.

Barroso WKS, Rodrigues CIS, Bortolotto LA, Mota-Gomes MA, Brandão AA, Feitosa ADM, et al. Diretrizes brasileiras de hipertensão arterial – 2020. Arq Bras Cardiol. 2021;116(3):516-658. https://doi.org/10.36660/abc.20201238 DOI: https://doi.org/10.36660/abc.20201238

Ribeiro AC, Uehara SCSA. Hipertensão arterial sistêmica como fator de risco para a forma grave da covid-19: revisão de escopo. Rev Saúde Pública. 2022;56:20. https://doi.org/10.11606/S1518-8787.2022056004311 DOI: https://doi.org/10.11606/s1518-8787.2022056004311

Alvim LM. A utilização do score de risco de Framingham para o manejo de pacientes portadores de hipertensão arterial e de diabetes mellitus: uma revisão integrativa para subsidiar um projeto de intervenção [trabalho de conclusão de curso]. Belo Horizonte: Universidade Federal de Minas Gerais (UFMG); 2014.

Nobre ALCSD, Lima CA, Oliveira MJL, Vieira DMA, Martelli Júnior H, Costa SM. Hipertensos assistidos em serviço de atenção secundária: risco cardiovascular e determinantes sociais de saúde. Cad Saúde Colet. 2020;28(3):334-44. https://doi.org/10.1590/1414-462X202028030386 DOI: https://doi.org/10.1590/1414-462x202028030386

Serotini BS, Perfetto GR, Locativa GM, El Hassam S. Complicações cardiovasculares associadas a COVID-19 e estratégias terapêuticas potenciais. Revista Corpus Hippocraticum. 2021;1(1).

Silva ARMC, Nery SBM, Bezerra GMD, Melo GA, Mendes JSA, Oliveira GAL, et al. Avaliação de risco cardiovascular pelo escore de framingham em hipertensos atendidos em uma unidade básica de saúde do município de Piripiri-PI. Res Soc Dev. 2021;10(4):e13810413909. https://doi.org/10.33448/rsd-v10i4.13909 DOI: https://doi.org/10.33448/rsd-v10i4.13909

Mesquita CT, Ker WS. Fatores de risco cardiovascular em cardiologistas certificados pela Sociedade Brasileira de Cardiologia: lições a serem aprendidas. Arq Bras Cardiol. 2021;116(4):782-3. https://doi.org/10.36660/abc.20210153 DOI: https://doi.org/10.36660/abc.20210153

Freitas EV, Brandão AA, Pozzan R, Magalhães ME, Fonseca F, Pizzi O, Campana É, Brandão AP. Importância da HDL-c para a ocorrência de doença cardiovascular no idoso. Arq Bras Cardiol. 2009;93(3):231-238. https://doi.org/10.1590/S0066-782X2009000900006 DOI: https://doi.org/10.1590/S0066-782X2009000900006